Albany, NY, United States of America

Sol J Daurn

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Winthrop Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sol J Daurn. Retrieved from https://idiyas.com/inventor/sol-j-daurn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sol J Daurn

Introduction

Sol J Daurn is a notable inventor based in Albany, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work focuses on innovative solutions for treating heart failure and hypertension.

Latest Patents

Sol J Daurn holds a patent for 6-substituted pyrazolo(3,4-d)pyrimidin-4-ones and compositions. This patent includes 6-substituted pyrazolo[3,4-d]pyrimidin-4-one derivatives, pharmaceutical compositions containing them, and methods for effecting c-GMP-phosphodiesterase inhibition. His invention aims to provide effective treatments for heart failure and hypertension.

Career Highlights

Daurn is associated with Sanofi Winthrop Inc., where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative compounds that address critical health issues. With a focus on improving patient outcomes, he continues to contribute to the field of medicine.

Collaborations

Throughout his career, Sol J Daurn has collaborated with esteemed colleagues, including Edward R Bacon and Baldev Singh. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

In summary, Sol J Daurn is a distinguished inventor whose work in pharmaceuticals has the potential to significantly impact the treatment of heart failure and hypertension. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…